Emergent balversa pharm order
Ended Awarded Last action
- Contract number
- 36C26024F0127
- Awardee
-
Janssen Biotech Inc. UEI NVYMGFA53MN7
- Awarding agency
-
Veterans Integrated Service Network 20
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $17,046
Award facts
- Contract value 100% obligated
- $17,046.33 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Horsham, PA 19044, USA
Award details come from SAM.gov/FPDS.
About this award
The Department of Veterans Affairs Veterans Health Administration awarded a $17,046 delivery order against GSA Schedule Pharmaceuticals and Drugs (FSS-61-IB) to Janssen Biotech, Inc. The order is for the anticancer medication Balversa (erdafitinib) to be delivered to a VA medical center in Horsham, Pennsylvania between December 2023 and February 2024. As the Veterans Health Administration works to provide comprehensive healthcare services to veterans, this order will help ensure patients have access to important specialty drugs through the VA's consolidated procurement process and agreements established under the GSA Schedule program. The award draws from Janssen's existing contract vehicle to streamline the delivery of needed pharmaceutical supplies to VA medical facilities.
Quick answers
Who was awarded contract 36C26024F0127?
36C26024F0127 was awarded to Janssen Biotech Inc. by Veterans Integrated Service Network 20 (Veterans Health Administration) on December 19, 2023.
How much is contract 36C26024F0127 worth?
The government has obligated $17,046 on 36C26024F0127.
Is contract 36C26024F0127 an order under another contract?
Yes. 36C26024F0127 is a delivery order under 36F79719D0217, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C26024F0127 competed?
The extent of competition for 36C26024F0127 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award